Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.71 |
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.71 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.71 |
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | ACHE | P22303 | 1/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | BLM | P54132 | 2/20 | 0.69 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.69 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.66 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 3/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7576777 | 0.98 | TDP1 (0.72) | TDP1ALDH1A1LMNASLC22A2SLC22A1 | |
| SCHEMBL28198442 | 0.91 | ALDH1A1 (0.68) | TDP1ALDH1A1LMNASLC22A2SLC22A1 | |
| SCHEMBL9628332 | 0.90 | NAAA (0.64) | TDP1ALDH1A1LMNASLC22A2SLC22A1 | |
| SCHEMBL1499569 | 0.90 | TDP1 (0.92) | TDP1ALDH1A1LMNASLC22A2SLC22A1 | |
| SCHEMBL10872900 | 0.89 | LMNA (0.62) | TDP1ALDH1A1LMNASLC22A2SLC22A1 | |
| SCHEMBL9254351 | 0.88 | ALDH1A1 (0.74) | TDP1ALDH1A1LMNASLC22A2SLC22A1 | |
| SCHEMBL16260997 | 0.87 | TDP1 (0.60) | TDP1ALDH1A1LMNASLC22A2SLC22A1 | |
| SCHEMBL10872544 | 0.87 | TDP1 (0.60) | TDP1ALDH1A1LMNASLC22A2SLC22A1 | |
| SCHEMBL10872304 | 0.87 | TDP1 (0.60) | TDP1ALDH1A1LMNASLC22A2SLC22A1 | |
| SCHEMBL12767062 | 0.86 | MCHR1 (0.64) | TDP1ALDH1A1LMNASLC22A2SLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3836912-B1 | COMBINATIONS OF SUBSTITUTED BENZAMIDES AND 5-ASA AGENTS | PHARMACYL AB (SE) | 2024-05-01 | — | — | EP | claimed |
| EP-1562640-B1 | METHODS FOR PURIFYING RADIOLABELLED COMPOUNDS | UNIV MCMASTER (CA) | 2012-12-05 | — | — | EP | claimed |
| CN-101663267-A | Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use | UNIMED PHARMA SPOL SRO | 2010-03-03 | — | — | CN | claimed |
| US-7335347-B2 | Methods for purifying radiolabelled compounds | MCMASTER UNIVERSITY (CA) | 2008-02-26 | — | — | US | claimed |
| EP-1562640-A2 | METHODS FOR PURIFYING RADIOLABELLED COMPOUNDS | Molecular Insight Pharmaceuticals, Inc. (US) | 2005-08-17 | — | — | EP | claimed |
| US-20040260073-A1 | Methods for purifying radiolabelled compounds | MCMASTER UNIVERSITY (CA) | 2004-12-23 | — | — | US | claimed |
| WO-2004035744-A2 | METHODS FOR PURIFYING RADIOLABELLED COMPOUNDS | BIOSTREAM, INC. (US) | 2004-04-29 | — | — | WO | claimed |
| EP-1127051-A2 | TRICYCLIC PYRAZOLE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-29 | — | — | EP | claimed |
| WO-2000027822-A2 | TRICYCLIC PYRAZOLE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-18 | — | — | WO | claimed |
| US-20260139240-A1 | SUBTILASE CYTOTOXIN B SUBUNIT MUTANT | GRIFFITH UNIVERSITY (AU) | 2026-05-21 | — | — | US | disclosed |
| CN-122037555-A | Flame-retardant high-resistivity bending-resistant polyamide composition and processing method thereof | 山东大杼新材料有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12480021-B2 | Composition for semiconductor process, method for preparing the same and method for preparing semiconductor device using the same | SK ENPULSE CO., LTD. (KR) | 2025-11-25 | — | — | US | disclosed |
| EP-4622671-A1 | NANOPARTICLE DISPERSIONS COMPRISING THERAPEUTIC AGENTS | Morrison, Eric (US) | 2025-10-01 | — | — | EP | disclosed |
| US-20250213473-A1 | HIGHLY TRANSPARENT WATER CONTINUOUS DENSE NANOLIPID FLUID (DNLF) DISPERSIONS AND METHOD OF PREPARATION USING A TWIN SCREW EXTRUDER | MORRISON Eric (US) | 2025-07-03 | — | — | US | disclosed |
| US-4326067-A | FROM OXAZOLINE WITH AN AMINE | THE DOW CHEMICAL COMPANY (US) | 1982-04-20 | — | — | US | disclosed |
| EP-0028331-A1 | Process for preparing urethanes | BAYER AG (DE) | 1981-05-13 | — | — | EP | disclosed |
| EP-0027940-A1 | Process for preparing urethanes | BAYER AG (DE) | 1981-05-06 | — | — | EP | disclosed |
| EP-0027952-A1 | Process for preparing N,O-disubstituted urethanes | BAYER AG (DE) | 1981-05-06 | — | — | EP | disclosed |
| EP-0027953-A1 | Process for preparing N,O-disubstituted urethanes | BAYER AG (DE) | 1981-05-06 | — | — | EP | disclosed |
| US-4006232-A | Therapeutic method of treating cardiac arrhythmias utilizing 3-substituted diphenylhydantoins | MILES LABORATORIES, INC. (US) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139240-A1 | SUBTILASE CYTOTOXIN B SUBUNIT MUTANT | ENGASE, SPPL2B, NEU2 | TDP1 1490/4885ALDH1A1 4316/4885LMNA 984/4885 |
| US-20040260073-A1 | Methods for purifying radiolabelled compounds | PAICS, PFAS, NPEPPS | TDP1 2547/4885ALDH1A1 2125/4885LMNA 3978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.